Open AccessEnoxaparin in cardiovascular disease: how to improve effectiveness and safety?
Author(s) -
И. С. Явелов
Publication year - 2011
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2011-6-112-123
Subject(s) - medicine , atrial fibrillation , intensive care medicine , disease , venous thromboembolism , acute coronary syndrome , balance (ability) , heparin , cardiology , physical therapy , myocardial infarction , thrombosis
The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly age, heparin medication change, or abnormal body weight), when the optimal balance between effectiveness and safety requires modifying the standard treatment protocols.